Donald L. Battle

Donald Battle serves as the Program Point of Contact for the Centers for Disease Control and Prevention, playing a critical role in aligning procurement activities with the agency’s public health mission. He facilitates the acquisition of scientific, diagnostic, and supply chain resources essential to disease surveillance, laboratory capacity building, and emergency response operations. Working closely with program scientists and procurement staff, Battle ensures that contract actions support CDC’s strategic priorities in infectious disease control, environmental health monitoring, and real-time data analytics. His responsibilities span the full lifecycle of acquisitions, from requirement development to contract closeout, with a focus on high-stakes, technically complex procurements in life sciences and public health infrastructure. Battle maintains sustained relationships with leading pharmaceutical and medical supply vendors, including Merck Sharp & Dohme LLC, GlaxoSmithKline LLC, Pfizer Inc., Sanofi Pasteur Inc., and McKesson Specialty Distribution LLC. These partnerships are primarily centered on the procurement of vaccines, diagnostic reagents, laboratory instruments, and specialized distribution services critical to national immunization and outbreak response efforts. His contracting patterns reflect a preference for established, high-capacity industry partners with proven regulatory compliance and cold-chain logistics expertise, ensuring reliable delivery of mission-critical biological and medical products. His procurement portfolio exhibits minimal use of socioeconomic set-asides, with 87.9% of awards issued under open competition and only 12.1% designated as total small business set-asides under FAR 19.5. This reflects the technical specificity and scale of CDC’s needs, which often require manufacturers with FDA-registered facilities and validated production capabilities not typically available in small business portfolios. The majority of his acquisitions fall under NAICS 334516 (Analytical Laboratory Instrument Manufacturing), indicating a strong focus on high-performance diagnostic equipment and sequencing platforms. He also regularly procures specialized chemical reagents under NAICS 325199 and 325998, as well as scientific consulting services under NAICS 541990 and 541690, demonstrating deep expertise in laboratory science, bioanalytical technology, and public health technical services.